Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC

Condition:   Medullary Thyroid Carcinoma
Interventions:   Drug: 111In-CP04;   Drug: 111In-CP04 with co-administration of gelofusine/gelaspan
Sponsors:   Paola Anna Erba;   Jagiellonian University Medical College;   University Hospital Freiburg;   Medical University Innsbruck;   University Medical Centre Ljubljana;   NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland;   Erasmus Medical Center;   INRASTES, NCSR Demokritos, Athens, Greece
Recruiting - verified August 2017

http://ift.tt/2uvinVL